Clinical Trial Update: Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating metformin to address antipsychotic-induced weight gain in adults with intellectual disability and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental Disability
• Intellectual Disability
• Obesity

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Intellectual Disability, Developmental Disability | Phase 4 | Status: RECRUITING